The Prognostic Role of CDK9 in Bladder Cancer.
Jędrzej BorowczakKrzysztof SzczerbowskiMateusz ManiewskiMarek ZdrenkaPiotr SłupskiPaulina AntosikSylwia KołodziejskaMarta Sekielska-DomanowskaMariusz DubielMagdalena BodnarŁukasz SzylbergPublished in: Cancers (2022)
High CDK9 expression predicts a favorable prognosis in urothelial carcinoma and is associated with clinicopathological features characteristic for early-stage disease. The decrease in CDK9 expression can be associated with the build-up of genetic instability and may indicate a key role for CDK9 in the early stages of urothelial carcinoma.